Karman Holdings Inc. KRMN
New risk paragraphs, branching off last year
Each branch is a paragraph in Risk Factors with nothing like it in the 10-K filed Apr 10, 2025. A box jumps to the paragraph as filed, below.
Paragraphs with nothing like them in last year's 10-K
5 paragraphs in Risk Factors of the 10-K filed Apr 3, 2026 with nothing like them in the 10-K filed Apr 10, 2025. Quoted exactly. Paragraphs that were only edited are under 10-K change.
see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Key Financial and Non-GAAP Operating Measures.”
For information on our cybersecurity risk management, strategy and governance, see Item 1C. - Cybersecuirty.
Refer to Item 9A. Controls and Procedures included in this Annual Report on Form 10-K for details of the material weaknesses exist as of December 31, 2025.
Our stock price may be volatile, and an investment in our common stock could suffer a decline in value.
There has been significant volatility in the market price and trading volume of equity securities, which is unrelated to the operating performance of the companies issuing the securities. These market fluctuations may negatively affect the market price of our common stock. Stockholders may not be able to sell their shares at or above the purchase price due to fluctuations in the market price of our common stock. Such changes could be caused by changes in our operating performance or prospects, including possible changes due to the cyclical nature of the aerospace industry and other factors such as fluctuations in OEM and aftermarket ordering, which could cause short-term swings in profit margins. Or such changes could be unrelated to our operating performance, such as changes in market conditions affecting the stock market generally or the stocks of aerospace companies or changes in the outlook for our common stock, such as changes to or the confidence in our business strategy, changes to or confidence in our management, or expectations for future growth of the Company.
Paragraphs in the 10-Q filed Nov 6, 2026 that were not in the one before
New in the latest 10-Q
32 paragraphs in the 10-Q filed Nov 6, 2026 with nothing like them in the 10-Q filed Aug 11, 2026 (at least half the words must differ; new numbers alone do not count). Quoted exactly, grouped by the item heading above them. This is text that changed, not a judgement of how serious it is.
Financial statements and notes
As of September 30, 2026, the Company elected to change its method of disclosing remaining performance obligations (“RPO”) to provide a more comprehensive view of its total contracted backlog and future revenue visibility. Historically, the Company utilized the practical expedient available under ASC 606-10-50-14, which allowed for the exclusion of contracts with an original expected duration of one year or less. The RPO as of December 31, 2025 would have been $667.6 million under the new disclosure methodology. This change impacted disclosure only and had no effect on the Company’s condensed consolidated balance sheets, statement of operations and comprehensive income, or cash flows.
Read in the 10-Q
As of September 30, 2026, the Company had $1.5 billion of RPO. The Company expects to recognize approximately 15% of the remaining performance obligations as revenue in the fourth quarter of 2026, 36% in 2027, and 49% thereafter.
Read in the 10-Q
The Company generally recognizes revenue over time using the input method, measured by the percentage of total costs incurred to-date relative to estimated total anticipated costs for each contract. This method is used because the Company considers total costs to be the best available measure of progress toward satisfaction of its performance obligations. Use of the input method requires the Company to make reasonable estimates regarding the costs associated with the design, manufacture, and delivery of its products.
Read in the 10-Q
The Company estimates profit on these contracts as the difference between total estimated revenue and total estimated costs at completion (“EAC”) and recognizes profit as costs are incurred. Significant judgment is used to estimate total costs at completion. Cost
Read in the 10-Q
6. Goodwill and Intangible Assets The table below summarizes the changes in the Company’s goodwill balances: Total Goodwill (in thousands) Balance at January 1, 2025 $ 225,146 Acquisitions 127,367 Impairments - Balance at December 31, 2025 352,513 Acquisitions 199,243 Impairments - Foreign Currency Translation (1,118) Balance at September 30, 2026 $ 550,638 The table below summarizes the carrying amounts of the Company’s identifiable intangible assets as of September 30, 2026 and December 31, 2025, respectively: As of September 30, 2026 As of December 31, 2025 Weighted Average Amortization Period Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount (in years) (in thousands) Trade Names (3.0 years) 3.0 $ 2,000 $ (444) $ 1,556 $ - $ - $ - ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── Patents (9 years) 9.0 2,722 (1,303) 1,419 2,722 (1,076) 1,646 Know-How (7.0 - 15.0 years) 10.2 40,324 (4,359) 35,965 15,686 (1,841) 13,845 Customer Backlogs (0.8 - 7.5 years) 3.2 75,233 (49,582) 25,651 47,750 (39,782) 7,968 Customer Relationships (10.0 - 19.0 years) 16.6 359,852 (86,466) 273,386 333,300 (70,871) 262,429 Customer Contracts (8.0 years) 8.0 17,500 (1,458) 16,042 - - - Total Intangible Assets $ 497,631 $ (143,612) $ 354,019 $ 399,458 $ (113,570) $ 285,888 Amortization expense was $9.9 million and $6.0 million for the three months ended September 30, 2026 and 2025, respectively, which was recorded in general and administrative expenses in the accompanying condensed consolidated statements of operations and comprehensive income. Amortization expense was $30.0 million and $15.9 million for the nine months ended September 30, 2026 and 2025, respectively, which was recorded in general and administrative expenses in the accompanying condensed consolidated statements of operations and comprehensive income.
Read in the 10-Q
Show the other 27
7. Debt The Company’s debt obligations consisted of the following as of September 30, 2026 and December 31, 2025: September 30, December 31, 2026 2025 (in thousands) ────────────────────────────────────────────────────────────────────────────────────────────────────────── Term loan $ 861,803 $ 502,800 Notes payable 4,420 3,967 Total debt 866,223 506,767 Less: unamortized debt issuance costs (7,416) (7,619) Less: current portion (7,312) (3,836) Long-term debt, net of current portion 851,495 495,312 On April 1, 2025, the Company entered into a Credit Agreement, by and among the Company, the lenders from time to time party thereto and Citibank, N.A., as administrative agent (the “Original Credit Agreement”). The Original Credit Agreement provided for (i) a revolving credit facility in an aggregate principal amount of $50 million (the “Revolving Credit Facility”) and (ii) a term loan facility in
Read in the 10-Q
an aggregate principal amount of $300 million (the “Term Loan Facility” and, together with the Revolving Credit Facility, the “Senior Credit Facility”). The maturity date of the Revolving Credit Facility is April 1, 2030, and the maturity date of the Term Loan Facility is April 1, 2032. The obligations under the Original Credit Agreement are secured by a lien on substantially all of the assets of the Company and certain of its direct and indirect subsidiaries. Loans under the Senior Credit Facility may be denominated only in U.S. dollars.
Read in the 10-Q
On May 27, 2025, the Company entered into that certain First Amendment to Credit Agreement (the “First Amendment”), which amends the Original Credit Agreement. The First Amendment provided for an incremental term loan in an aggregate principal amount of $75 million, thereby increasing the aggregate principal amount of the Term Loan Facility.
Read in the 10-Q
On October 24, 2025, the Company entered into that certain Second Amendment to Credit Agreement (the “Second Amendment”), which amends the Original Credit Agreement. The Second Amendment provided for an incremental term loan in an aggregate principal amount of $130 million, thereby increasing the aggregate principal amount of the Term Loan Facility.
Read in the 10-Q
The amendments to the Credit Agreement are accounted for as debt modifications. During the three and nine months ended September 30, 2026, the Company incurred debt issuance costs of $1.4 million and $4.0 million, respectively, in connection with the amendments. For the three and nine months ended September 30, 2025, the Company recorded debt issuance costs of $0 and $6.5 million, respectively. The Company recorded a loss on debt extinguishments of $2.6 million, which is recorded in interest expense, net within the condensed consolidated statements of operations and comprehensive income, during the three and nine months ended September 30, 2026. No loss on debt extinguishments was recorded for the three and nine months ended September 30, 2025.
Read in the 10-Q
During the three months ended September 30, 2026, the Company recorded a $3.3 million out-of-period adjustment to correct the prior capitalization of debt issuance costs that should have been expensed in connection with the Third Amendment during the three months ended March 31, 2026. The Company evaluated the impact of the error and out-of-period adjustment and concluded it was not material to the current or any previously issued interim condensed consolidated financial statements.
Read in the 10-Q
14. Income Tax Expense (Benefit) The following table summarizes the Company’s income tax expense and effective tax rate for the three and nine months ended September 30, 2026 and 2025: Three Months Ended September 30, Nine Months Ended September 30, 2026 2025 2026 2025 (in thousands, except percentages) ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── Income before provision for income taxes $ 13,305 $ 11,861 $ 41,202 $ 18,962 Income tax expense (benefit) (7,603 4,217 (1,532 9,309 Effective tax rate (57.1 35.6% (3.7 49.1% The Company calculates its interim tax provision using its best estimate of the annual effective tax rate. During the three months ended September 30, 2026, the Company completed two years of a multi-year study of its U.S. federal research and development (“R&D”) tax credits, identifying additional qualifying R&D expenditures that resulted in a $7.8 million net income tax benefit attributed to prior years, net of associated uncertain tax position reserve. Additionally, based on the same study, the Company revised its current year estimate of R&D tax credits by an additional $7.4 million, net of unrecognized tax benefits, to update its best estimate of the annual effective tax rate for the year ending December 31, 2026. As a result, the Company’s effective income tax rate is (57.1)% and (3.7)% for the three and nine months ended September 30, 2026, respectively. The Company is currently in the process of completing U.S. federal and state R&D tax credit studies for 2023 and 2024 tax years, as well as completing its 2025 state R&D study, which is expected to be completed in the fourth quarter of 2026. While timing of completion is uncertain, the Company expects the resulting income tax benefits recognized to be material to its financial statements. The Company expects to record these income tax benefits within the next twelve months as the studies are completed. For the nine months ended September 30, 2026, in addition to the aforementioned benefit related to incremental R&D credits, the effective tax rate included a benefit related to the revaluation of the Company’s state deferred tax liabilities arising from the changes in the combined state tax rate following the Seemann Acquisition.
Read in the 10-Q
As a result of the Walker Acquisition, the Company is subject to U.S. federal income tax on certain earnings of its foreign subsidiaries that are treated as controlled foreign corporations (“CFCs”) under the Global Intangible Low-Taxed Income (GILTI) regime, which was amended and renamed as Net CFC Tested Income (NCTI) under the One Big Beautiful Bill Act (Public Law 119-21), enacted July 4, 2025. The Company has elected to treat the tax effects of NCTI as a period cost in accordance with ASC 740, Income Taxes, and accordingly, recognizes any related tax expense in the period in which the tax arises, and no deferred tax assets or liabilities will be recognized for temporary differences that are expected to affect future NCTI calculations. No NCTI expense was recorded in the three and nine months ended September 30, 2026.
Read in the 10-Q
Additionally, the Company has not recognized a deferred tax liability on the excess of book over tax basis in its investment in the foreign subsidiaries acquired in the Walker Acquisition, as the Company intends to reinvest those earnings indefinitely outside the United States. It is not practicable to determine the unrecognized deferred tax liability related to this difference.
Read in the 10-Q
Income tax benefit was ($7.6) million and income tax expense was $4.2 million for the three months ended September 30, 2026 and 2025, respectively. The effective tax rate was (57.1)% and 35.6% for the three months ended September 30, 2026 and 2025, respectively. The current period income tax benefit resulted in a negative effective tax rate, which was primarily driven by the U.S. federal R&D tax credits, net of unrecognized tax benefits.
Read in the 10-Q
Income tax benefit was ($1.5) million and income tax expense was $9.3 million for the nine months ended September 30, 2026 and 2025, respectively. The effective tax rate was (3.7)% and 49.1% for the nine months ended September 30, 2026 and 2025, respectively. The current year negative effective tax rate was primarily attributable to the R&D tax credit as discussed above, as well as a tax benefit related to the revaluation of our state deferred tax liabilities arising from the changes in the combined state tax rate following the Seemann Acquisition.
Read in the 10-Q
EBITDA, Adjusted EBITDA and Adjusted EBITDA Margin are driven by changes in volume, performance, contract mix and general and administrative expenses and investment levels. Performance, as used in this definition, refers to changes in profitability
Read in the 10-Q
and is primarily based on adjustments to estimates at completion on individual contracts. These adjustments result from increases or decreases to the estimated value of the contract, the estimated costs to complete the contract, or both.
Read in the 10-Q
Free Cash Flow represents net cash provided by (used in) operating activities in the period less payments for property and equipment made in the period.
Read in the 10-Q
(6) Represents items we believe are not indicative of our underlying business performance, including estimated legal settlements and related professional fees. Such costs are inconsistent in both amount and frequency.
Read in the 10-Q
related to the extinguishments of debt. We believe that these adjustments are not indicative of our underlying business performance.
Read in the 10-Q
The following table reconciles net cash provided by (used in) operating activities, a GAAP measure, to Free Cash Flow, a non-GAAP measure. The effect of exchange rate changes on cash and cash equivalents was immaterial.
Read in the 10-Q
Free Cash Flow is considered a non-GAAP financial measure under the SEC’s rules. Management believes, however, that Free Cash Flow is an important financial measure for use in evaluating the Company’s financial performance, as it measures our ability to generate additional cash from our business operations. Free Cash Flow should be considered in addition to, rather than as a substitute for, net income as a measure of our performance or net cash provided by (used in) operating activities as a measure of our liquidity. Additionally, our definition of Free Cash Flow is limited and does not represent residual cash flows available for discretionary expenditures due to the fact that the measure does not deduct the payments required for debt service and other obligations or payments made for business acquisitions. Therefore, we believe it is important to view Free Cash Flow as supplemental to our entire statement of cash flows.
Read in the 10-Q
On April 1, 2025, we entered into a Credit Agreement, by and among the Company, the lenders from time to time party thereto and Citibank, N.A., as administrative agent (the “Original Credit Agreement”). The Original Credit Agreement provided for (i) a revolving credit facility in an aggregate principal amount of $50 million (the “Revolving Credit Facility”) and (ii) a term loan facility in an aggregate principal amount of $300 million (the “Term Loan Facility” and, together with the Revolving Credit Facility, the “Senior Credit Facility”). The maturity date of the Revolving Credit Facility is April 1, 2030, and the maturity date of the Term Loan Facility is April 1, 2032. The obligations under the Original Credit Agreement are secured by a lien on substantially all of our assets and certain of our direct and indirect subsidiaries. Loans under the Senior Credit Facility may be denominated only in U.S. dollars.
Read in the 10-Q
On May 27, 2025, we entered into that certain First Amendment to Credit Agreement (the “First Amendment”), which amends the Original Credit Agreement. The First Amendment provided for an incremental term loan in an aggregate principal amount of $75 million, thereby increasing the aggregate principal amount of the Term Loan Facility.
Read in the 10-Q
On October 24, 2025, we entered into that certain Second Amendment to Credit Agreement (the “Second Amendment”), which amends the Original Credit Agreement. The Second Amendment provided for an incremental term loan in an aggregate principal amount of $130 million, thereby increasing the aggregate principal amount of the Term Loan Facility.
Read in the 10-Q
On August 26, 2026, we entered into that certain Sixth Amendment to Credit Agreement (the “Sixth Amendment”), which amends the Original Credit Agreement (as amended by the First Amendment, Second Amendment, Third Amendment, Fourth Amendment, Fifth Amendment and Sixth Amendment, the “Credit Agreement”). Under the Sixth Amendment, we increased the principal amount of the Term Loan Facility by $100 million, for an aggregate principal amount of $864 million.
Read in the 10-Q
The amendments to the Credit Agreement are accounted for as debt modifications. During the three and nine months ended September 30, 2026, we incurred debt issuance costs of $1.4 million and $4.0 million, respectively, in connection with the amendments. For the three and nine months ended September 30, 2025, we recorded debt issuance costs of $0 and $6.5 million, respectively. We recorded a loss on debt extinguishments of $2.6 million which is recorded in interest expense, net within the condensed consolidated statements of operations and comprehensive income, during the three and nine months ended September 30, 2026. No loss on debt extinguishments was recorded for the three and nine months ended September 30, 2025.
Read in the 10-Q
During the three months ended September 30, 2026, we recorded a $3.3 million out-of-period adjustment to correct the prior capitalization of debt issuance costs that should have been expensed in connection with the Third Amendment during the three months ended March 31, 2026. We evaluated the impact of the error and out-of-period adjustment and concluded it was not material to any previously issued interim condensed consolidated financial statements.
Read in the 10-Q
The Credit Agreement contains affirmative and negative covenants customary for secured credit facilities of this nature, including, among others, limitations on the Company and its subsidiaries with respect to liens, the incurrence of indebtedness, dispositions and certain fundamental changes.
Read in the 10-Q
Other information
The following members of our Board of Directors and officers adopted, modified or terminated a trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act (a “Rule 10b5-1 Trading Arrangement”): Name Title of Director or Officer Action Date Total Shares of Common Stock to Be Sold Expiration Date Tony Koblinski Director Adoption 9/9/2026 100,000 9/1/2027 Michael Willis Chief Financial Officer Termination 9/11/2026 185,000* N/A ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── * The Rule 10b5-1 Trading Arrangement was adopted on February 2, 2026, for sales through November 13, 2026. No shares of common stock were sold under the Rule 10b5-1 Trading Arrangement prior to termination.
Read in the 10-Q
Item 6
Exhibit No. Title of Document 10.1 Fifth Amendment to Credit Agreement, dated August 3, 2026, by and among the Company, the lenders party thereto, and Citibank, N.A., as administrative agent (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed with the SEC on August 6, 2026) 10.2 Sixth Amendment to Credit Agreement, dated August 26, 2026, by and among the Company, the lenders party thereto, and Citibank, N.A., as administrative agent (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed with the SEC on August 28, 2026) 10.3+ Offer Letter, dated August 19, 2026, by and between Karman Space & Defense LLC and Chris Boynton (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed with the SEC on August 27, 2026) 31.1* Certification of the Chief Executive Officer pursuant to Rule 13a-14(a) of the Exchange Act, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 31.2* Certification of the Chief Financial Officer pursuant to Rule 13a-14(a) of the Exchange Act, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 32.1** Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 32.2** Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 101. INS* Inline XBRL Instance Document 101. SCH* Inline XBRL Taxonomy Extension Schema Document 101. CAL* Inline XBRL Taxonomy Extension Calculation Linkbase Document 101. DEF* Inline XBRL Taxonomy Extension Definition Linkbase Document 101. LAB* Inline XBRL Taxonomy Extension Label Linkbase Document 101. PRE* Inline XBRL Taxonomy Extension Presentation Linkbase Document 104* Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101)
Read in the 10-Q
The 10-Q's risk factors against the 10-K
Item 1A of the 10-Q filed Nov 6, 2026 against Item 1A of the 10-K filed Apr 3, 2026.
A 10-Q repeats only the risks that changed, so a 10-K paragraph that is missing from it is not counted as removed.
Added is a paragraph with nothing like it in the 10-K, Reworded a sentence that is in both with several words changed,
Quiet changes a sentence in both where one to four words changed and one is a hedge or a modal
(cut words struck through, new words highlighted).
Text on the page, not a score; each links to the filing at sec.gov.
Phrases used for the first time
Two-word phrases in Risk Factors of the 10-K filed Apr 3, 2026 that are in none of the 1 earlier 10-Ks stored, back to Apr 10, 2025
Where each one is used
- rapidly developed: The technological complexity of our business has increased significantly over the last several years. This increased complexity and our expected growth has placed, and will continue to place, a strain on our management and our administrative, operational and financial infrastructure. Artificial intelligence (“AI”)...
- cannot successfully: The technological complexity of our business has increased significantly over the last several years. This increased complexity and our expected growth has placed, and will continue to place, a strain on our management and our administrative, operational and financial infrastructure. Artificial intelligence (“AI”)...
- timely cost-effective: The technological complexity of our business has increased significantly over the last several years. This increased complexity and our expected growth has placed, and will continue to place, a strain on our management and our administrative, operational and financial infrastructure. Artificial intelligence (“AI”)...
- cost-effective compliant: The technological complexity of our business has increased significantly over the last several years. This increased complexity and our expected growth has placed, and will continue to place, a strain on our management and our administrative, operational and financial infrastructure. Artificial intelligence (“AI”)...
- responsible manner: The technological complexity of our business has increased significantly over the last several years. This increased complexity and our expected growth has placed, and will continue to place, a strain on our management and our administrative, operational and financial infrastructure. Artificial intelligence (“AI”)...
- revenues earnings: could cause federal government agencies to reduce their purchases under contracts, to exercise their right to terminate contracts at any time without penalty or not to exercise options to renew contracts, any of which could result in decreased sales of our products. In addition, any disruptions in federal...
- dow budget: A significant portion of our net sales is generated from the military defense market. The military and defense market is significantly dependent upon government budget trends, particularly the DoW budget. In addition to normal business risks, our supply of products to the U.S. government is subject to unique risks...
Used at least twice, small words left out. Counted, not picked: a phrase can be new because the company renamed something.
What was taken out
21 paragraphs of last year's Risk Factors with nothing like them now. The longest are quoted.
Sources
Item 1A of each 10-K and 10-Q on EDGAR, quoted exactly. Each paragraph links to the filing at sec.gov.
Also
10-K change: what was reworded or cut, section by section.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/KRMN/export.csv") into a cell.